Both in Pharmaceuticals
Aclaris Therapeutics vs Nuvectis Pharma
Over the past year ACRS returned +47.5% and NVCT returned +199.3%; their daily moves had a correlation of 0.14.
ACRS +47.5% NVCT +199.3%Growth of $1, one year, split-adjusted
| Metric | ACRS | NVCT |
|---|---|---|
| Price | $3.78 | $19.04 |
| Market cap | $585.1M | $621.4M |
| Today | −0.66% | −0.76% |
| 1 month | −11.6% | −11.0% |
| 6 months | −20.5% | +96.0% |
| Year to date | +25.4% | +152.1% |
| 1 year | +49.8% | +183.7% |
| Revenue growth (YoY) | −8.3% | — |
| Gross margin | 86.6% | — |
| Net margin | −1320.1% | — |
| P/E (TTM) | — | — |
| Price / sales | 71.2× | — |
| Net cash | $91.6M | $22.2M |
| Dividend yield | — | — |
| Volatility (60d) | 75.7% | 68.0% |
| Short % of float | 12.4% | 11.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).